<DOC>
	<DOC>NCT01522521</DOC>
	<brief_summary>The purpose of this study is to investigate the efficacy and safety of AK156 in Japanese patients with primary osteoporosis.</brief_summary>
	<brief_title>Study of AK156 in Primary Osteoporosis Patients</brief_title>
	<detailed_description />
	<mesh_term>Osteoporosis</mesh_term>
	<criteria>Patients diagnosed with primary osteoporosis Patients who have vertebral fractures at the time of screening Patients diagnosed with secondary osteoporosis Patients with a current uncontrolled medical disorder or other condition which makes the patient unsuitable for the study</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>89 Years</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>AK156</keyword>
</DOC>